Protein kinases of the human malaria parasite Plasmodium falciparum: the kinome of a divergent eukaryote.

Ward P, Equinet L, Packer J, Doerig C. · 2004

Read Protein kinases of the human malaria parasite Plasmodium falciparum: the kinome of a divergent eukaryote. by Ward P, Equinet L, Packer J, Doerig C. (2004) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc526369.txt.

Introduction

Pauline Ward, Leila Equinet, Jeremy Packer, and Christian Doerig catalogued the protein kinases of the malaria parasite Plasmodium falciparum in BMC Genomics in 2004. Kinases are enzymes that switch proteins on and off by adding phosphate tags, and they control most cell processes, which makes them tempting drug targets. The parasite's genome had just been sequenced, opening a hunt for its full kinase set, or kinome. Searching the genome database with several tools found 65 kinase sequences.

Placing them on a family tree against the seven known kinase groups showed how distant this parasite is. Many of its kinases fell outside every known group, and none matched the tyrosine kinase or STE groups. The cell-cycle control group was the largest. A brand-new family of twenty, named FIKK after a shared sequence motif, appears only in this parasite's wider phylum, mostly in this species alone.

Catalog record

CREATORWard P, Equinet L, Packer J, Doerig C.
YEAR2004
COLLECTIONPAPERS
FORMATTXT
FILE SIZE73 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC526369

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Protein kinases of the human malaria parasite Plasmodium falciparum: the kinome of a divergent eukaryote By Pauline Ward, Leila Equinet, Jeremy Packer, Christian Doerig Published in: BMC Genomics DOI: 10.1186/1471-2164-5-79 ABSTRACT Abstract Background Malaria, caused by the parasitic protist Plasmodium falciparum, represents a major public health problem in the developing world. The P. falciparum genome has been sequenced, which provides new opportunities for the identification of novel drug targets. Eukaryotic protein kinases (ePKs) form a large family of enzymes with crucial roles in most cellular processes; hence malarial ePKS represent potential drug targets. We report an exhaustive analysis of the P. falciparum genomic database (PlasmoDB) aimed at identifying and classifying all ePKs in this organism. Results Using a variety of bioinformatics tools, we identified 65 malarial ePK sequences and constructed a phylogenetic tree to position these sequences relative to the seven established ePK groups. Predominant features of the tree were: (i) that several malarial sequences did not cluster within any of the known ePK groups; (ii) that the CMGC group, whose members are usually involved in the control of cell proliferation, had the highest number of malarial ePKs; and (iii) that no malarial ePK clustered with the tyrosine kinase (TyrK) or STE groups, pointing to the absence of three-component MAPK modules in the parasite. A novel family of 20 ePK-related sequences was identified and called FIKK, on the basis of a conserved amino acid motif. The FIKK family seems restricted to Apicomplexa, with 20 members in P. falciparum and just one member in some other Apicomplexan species. Conclusion The considerable phylogenetic distance between Apicomplexa and other Eukaryotes is reflected by profound divergences between the kinome of malaria parasites and that of yeast or mammalian cells. BACKGROUND Modulation of protein phosphorylation through the antagonistic effects of protein kinases and protein phosphatases is a major regulatory mechanism of most cellular processes. Dysregulation of protein phosphorylation in human cells plays a major role in many diseases such as cancers and neurodegenerative disorders [1]. This has prompted the search for drugs targeting protein kinases, an endeavour which led in 2002 to the commercialisation of Gleevec, the first protein kinase inhibitor used as a drug for human disease [2]. Additional molecules targeting protein kinases are in clinical trial [3,4], and significant developments in this field are expected in the next few years. Some of the most devastating infectious diseases are caused by protists such as malaria parasites and trypanosomatids: hence, about half the global population lives in malarious areas, with 10% of the world population contracting the disease each year, which results in 1–3 million annual deaths. The essential role played by eukaryotic protein kinases (ePKs) in crucial cellular functions makes them attractive potential targets for drugs against such eukaryotic infectious agents [5]. Malaria parasites have a complex life cycle. Infection of human beings by Plasmodium falciparum, the species responsible for the lethal form of human malaria, begins with the bite of an infected Anopheles mosquito, which delivers sporozoites into the bloodstream. These cells establish an infection inside hepatocytes, where they undergo an intense multiplication generating several thousand merozoites, a process called exo-erythrocytic schizogony. The merozoites invade erythrocytes, where they also undergo schizogony, the process that is responsible for malaria pathogenesis. Some merozoites, however, arrest the cell cycle and differentiate into male or female gametocytes, which are infective to the mosquito. Once ingested by the insect, the gametocytes develop into gametes (which for the male cells involves three rapid rounds of cell division) and fuse into a zygote. Further development in the mosquito involves a process of sporogony, producing sporozoites that accumulate in the salivary glands and are now ready to infect a new human host (see http://www.malaria.org for information on malaria). The observation that many parasitic ePKs display profound structural and functional divergences from their counterparts in their vertebrate hosts [5-7] suggests that specific inhibition is an attainable goal. The availability of PlasmoDB, a genomic database for Plasmodium falciparum [8], now permits a systematic analysis of the entire complement of ePKs encoded in the genome (the "kinome") of this pathogen, an important milestone both in our understanding of Plasmodium biology and in the definition of potential novel drug targets. Prior to the genomic era, the initial classification system of Hanks and Quinn [9] distributed ePKs into four major groups: • the cyclic-nucleotide- and calcium/phospholipid-dependent kinases (the AGC group); • the CMGC group, constituted of the cyclin-dependent- (CDK), mitogen-activated- (MAPK), glycogen-synthase- (GSK) and CDK-like kinases; • the calmodulin-dependent kinases (CaMK), and • the tyrosine kinases (TyrK). ePKs that did not clearly fit into any of these groups were placed into the OPK ("other protein kinases") group. The primary structure of all enzymes in these groups conform to the model described by Hanks, in which the catalytic domain is subdivided into eleven subdomains, which can be aligned across all groups. In addition to the "typical" ePKs, several enzymes possessing protein kinase activity, but which are unrelated (or only distantly related) to ePKs at the primary structure level, have been identified and termed "atypical protein kinases" (aPKs). These include phosphatidyl-inositol 3' kinase (PI3K), DNA-dependent protein kinase, and members of pyruvate dehydrogenase kinase family. Exhaustive analyses of the kinome of some model organisms have now been published. The kinome of S. cerevisiae contains 115 ePKs [10], and the genomes of D. melanogaster, C. elegans and H. sapiens comprise 239, 454 and 510–520 ePK-coding genes, respectively [11-14]. On the basis of this wealth of new data, three additional major ePK groups were recognized (reviewed in [15]: • the casein kinase 1 (CK1) group; • the STE group, which includes many enzymes functioning in MAPK pathways, although the MAPKs themselves belong to the CMGC group (STE stands for "sterile", referring to the fact that enzymes belonging to this group were first identified in genetic analysis of yeast sterile mutants); • the tyrosine kinase-like (TKL) group, which, as its name indicates, includes enzymes that are related to those in the TyrK group, although they are serine-threonine protein kinases. Furthermore, a description of the 369 non-receptor serine/threonine protein kinases of the plant Arabidopsis thaliana has recently been published [16]. Comparative examination of this and previously available kinomes has demonstrated that members of all major ePK groups can be found in yeast, worms, insects, mammals and plants, with the exception of TyrKs, which are not found in yeast. That most TyrKs function in hormone-response receptor-linked pathways suggests that this family arose as an adaptation to the needs for intercellular communication in multicellular organisms. It has however been reported recently that a few unicellular eukaryotes (Chlamydomonoas, Entamoeba and Phytophtora) possess putative TyrK family members [17]. Despite the fact that most serine-threonine ePKs groups are found in all eukaryotes, indicating that their appearance occurred early in evolution, each of the kinomes has nevertheless its specificities. A striking feature in this respect is the considerable extension of some ePK families in some organisms but not in others. For example, yeast and Drosophila have 4 and 10 members of the casein kinase 1 (CK1) group respectively, whereas the C. elegans genome encodes 85 CK1-related genes. With the exception of the plant A. thaliana, all eukaryotes whose kinome has been characterised, from yeast to man, belong to the

Read the complete text